4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0000935836-25-000416
Director sold 1,976,137 shares at $2.87 ($5,672,106)
- Director acquired 1,867,605 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hively Brad · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-03 | Exercise or conversion : show line 1 in the form | +684,528 | $0.85 | $581,849 | 1,396,561 | D |
| 2025-06-03 | Exercise or conversion : show line 2 in the form | +105,320 | $0.48 | $50,659 | 1,501,881 | D |
| 2025-06-03 | Exercise or conversion : show line 3 in the form | +131,297 | $1.87 | $245,525 | 1,633,178 | D |
| 2025-06-03 | Exercise or conversion : show line 4 in the form | +946,460 | $0.85 | $804,491 | 2,579,638 | D |
| 2025-06-03 | Sale : show line 5 in the form | −1,867,605 | $2.87 | $5,360,587 | 712,033 | D |
| 2025-06-03 | Sale : show line 6 in the form | −108,532 | $2.87 | $311,519 | 603,501 | D |
| Open-market sales · 1,976,137 sh · avg $2.87 · $5,672,106 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-03 | Exercise or conversion : show line 7 in the form Non-Qualified Stock Option (right to buy) | +684,528 | 0 | D |
| 2025-06-03 | Exercise or conversion : show line 8 in the form Non-Qualified Stock Option (right to buy) | +105,320 | 0 | D |
| 2025-06-03 | Exercise or conversion : show line 9 in the form Non-Qualified Stock Option (right to buy) | +131,297 | 0 | D |
| 2025-06-03 | Exercise or conversion : show line 10 in the form Non-Qualified Stock Option (right to buy) | +946,460 | 0 | D |
Loading xslF345X05/ownership.xml…